Item 7.01 Regulation FD Disclosure.

On September 10, 2020, PDL BioPharma, Inc. posted to its website presentation materials that it will use during its webcast providing a business update on LENSAR, Inc. A copy of this presentation is attached hereto as Exhibit 99.1.

Limitation of Incorporation by Reference

In accordance with General Instruction B.2. of Form 8-K, this information, including the Exhibit, is furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Item 7.01 of this Current Report on Form 8-K will not be deemed an admission as to the materiality of any information that is required to be disclosed solely by Regulation FD.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits
                          Exhibit No.          Description
                               99.1           Presentation

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses